Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Cardiology

• Publication date

  2005-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2005.07.094PMID 16360361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease

  2005cited by this paper
• Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes.

  2004cited by this paper
• Natriuretic peptides for risk stratification of patients with acute coronary syndromes

  2004cited by this paper
• Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.

  2004cited by this paper
• Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

  2003cited by this paper
• Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes.

  2002cited by this paper
• Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

  2002cited by this paper
• Coronary Heart Disease

  2002cited by this paper
• The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

  2001cited by this paper
• Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

  2000cited by this paper
• Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations.

  2000cited by this paper
• Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

  1999cited by this paper
• Natriuretic peptides--relevance in cardiovascular disease.

  1998cited by this paper
• Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.

  1998cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation

  1998cited by this paper
• Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

  1996cited by this paper
• Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.

  1996cited by this paper
• Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.

  1996cited by this paper
• Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris.

  1995cited by this paper
• Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction.

  1995cited by this paper
• Relationship between plasma level of brain natriuretic peptide and myocardial infarct size.

  1994cited by this paper
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

  1985cited by this paper
• Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population.

  1983cited by this paper

• Acute type A aortic dissection rupture factors prediction using a hybrid ensemble model with feature selection and data augmentation

  2025cites this paper
• The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study

  2020cites this paper
• Differences of Serum NT-PROBNP Concentration and Echocardiographic Parameterspredict Extent and Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome

  2017cites this paper
• Association between serum N-terminal pro-B-type natriuretic peptide levels and characteristics of coronary atherosclerotic plaque detected by coronary computed tomography angiography

  2016cites this paper
• The predictive value of plasma biomarkers in discharged heart failure patients: the role of plasma BNP.

  2016cites this paper
• B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction

  2016cites this paper
• Valores intermediários de BNP são capazes de predizer eventos em pacientes com síndrome coronária aguda

  2016cites this paper
• Association of N‐terminal pro‐brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction

  2014cites this paper
• Clinical Study Additive Value of B-Type Natriuretic Peptide on Rest 201 Tl-Dipyridamole Stress 99 mTc-Sestamibi GatedMyocardial SPECT in Patients with Normal Left Ventricular Systolic Function

  2014cites this paper
• Association of high serum pro-BNP levels with severity of coronary artery disease and its limitations

  2014cites this paper
• Mean platelet volume predicts left descending artery occlusion in patients with non-ST-elevation myocardial infarction

  2014cites this paper
• Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome.

  2014cites this paper
• The potential role of natriuretic peptides in acute coronary syndrome stratification.

  2013cites this paper
• Serum Probnp Associated with the Severity of Coronary Artery Disease: its Limitation in Metabolic Syndrome

  2013cites this paper
• NT-proBNP is associated with SYNTAX score and aortic distensibility in patients with stable CAD

  2013cites this paper
• The role of B-type natriuretic peptide testing in patients with acute coronary syndromes.

  2012cites this paper
• Natriuretic peptides in heart failure: where we are, where we are going

  2011cites this paper
• Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention.

  2011cites this paper
• In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.

  2011cites this paper
• Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements

  2011cites this paper
• Correlation of cardiac troponin I levels (10 folds upper limit of normal) and extent of coronary artery disease in non-ST elevation myocardial infarction.

  2010cites this paper
• Additive Value of B-Type Natriuretic Peptide on Rest 201Tl-Dipyridamole Stress 99mTc-Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function

  2010cites this paper
• An evidence-based algorithm for the use of B-type natriuretic testing in acute coronary syndromes.

  2010cites this paper
• Comprehensive Review of the Relative Clinical Utility of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide Assays in Cardiovascular Disease

  2009cites this paper
• A comparison between B-type natriuretic peptide, Global Registry of Acute Coronary Events (GRACE) score and their combination in ACS risk stratification

  2009cites this paper
• Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.

  2009cites this paper
• Einfluss von Parametern des Gerinnungssystems und von "brain natriuretic peptide" (BNP) auf die Entstehung von In-Stent-Restenosen bei Patienten mit stabiler koronarer Herzerkrankung-eine Pilotstudie

  2009influential citation
• Valor do fator natriurético tipo B e de outras variáveis como preditores de localização do território de isquemia miocárdica aguda e para avaliação prognóstica no infarto agudo do miocárdio sem supradesnivelamento do segmento ST

  2008cites this paper
• Natriuretic peptides in coronary disease with non-ST elevation: new tools ready for clinical application?

  2007cites this paper
• Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.

  2006cites this paper
• What information can an invasive cardiologist obtain from brain natriuretic peptide?

  2006cites this paper
• Acute Coronary Syndromes: From The Laboratory Markers To The Coronary Vessels

  2006cites this paper